Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Vita Life Sciences Limited ( (AU:VLS) ) has issued an update.
Vita Life Sciences Limited announced the cessation of 226,873 of its ordinary fully paid securities due to an on-market buy-back, effective November 5, 2025. This move is part of the company’s capital management strategy, potentially impacting its market positioning by reducing the number of shares in circulation, which could influence shareholder value and market perception.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, focusing on the development and distribution of a range of health supplements and products. The company is known for its commitment to improving health and vitality through scientifically-backed products.
Average Trading Volume: 12,909
Technical Sentiment Signal: Buy
Current Market Cap: A$131.9M
For an in-depth examination of VLS stock, go to TipRanks’ Overview page.